Fjarde Ap Fonden Moderna, Inc. Transaction History

Fjarde Ap Fonden

$9.8 Billion
Q3 2024

A detailed history of Fjarde Ap Fonden transactions in Moderna, Inc. stock. As of the latest transaction made, Fjarde Ap Fonden holds 56,430 shares of MRNA stock, worth $2.08 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

56,430

Previous 50,430 11.9%

Holding current value

$2.08 Million

Previous $5.37 Million 29.83%

% of portfolio

0.04%

Previous 0.06%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$63.64 - $125.14 $381,840 - $750,840	6,000 Added 11.9%	56,430 $3.77 Million
Q1 2024 Apr 25, 2024	BUY	$85.37 - $115.44 $204,888 - $277,056	2,400 Added 5.0%	50,430 $5.37 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $208,530 - $313,290	-3,000 Reduced 5.88%	48,030 $4.78 Million
Q3 2023 Oct 23, 2023	SELL	$96.41 - $126.61 $86,769 - $113,949	-900 Reduced 1.73%	51,030 $5.27 Million
Q2 2023 Aug 02, 2023	BUY	$118.5 - $160.53 $450,300 - $610,014	3,800 Added 7.9%	51,930 $6.31 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $379,848 - $551,656	-2,800 Reduced 5.5%	48,130 $7.39 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $1.16 Million - $2.06 Million	-9,800 Reduced 16.14%	50,930 $9.15 Million
Q2 2022 Aug 11, 2022	SELL	$117.13 - $176.59 $2.82 Million - $4.26 Million	-24,100 Reduced 28.41%	60,730 $8.68 Million
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $417,318 - $775,665	-3,300 Reduced 3.74%	84,830 $14.6 Million
Q4 2021 Feb 15, 2022	SELL	$225.82 - $368.51 $1.11 Million - $1.82 Million	-4,930 Reduced 5.3%	88,130 $22.4 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $2.48 Million - $5.41 Million	-11,170 Reduced 10.72%	93,060 $35.8 Million
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $1.21 Million - $2.19 Million	9,300 Added 9.8%	104,230 $24.5 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $98,262 - $167,382	900 Added 0.96%	94,930 $12.4 Million
Q4 2020 Feb 12, 2021	SELL	$65.74 - $169.86 $203,793 - $526,566	-3,100 Reduced 3.19%	94,030 $9.82 Million
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $70,642 - $123,304	1,300 Added 1.36%	97,130 $6.87 Million
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $2.84 Million - $7.67 Million	95,830 New	95,830 $6.15 Million

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account